First Tracks Biotherapeutics closes private placement of 6,106,870 shares
TRAX•First Tracks Biotherapeutics closed a private placement of 6,106,870 common shares on October 19, 2026. A registration rights agreement requires it to file or confidentially submit an SEC registration statement covering investors’ resales within 30 days of closing.
1. Placement closed
First Tracks Biotherapeutics closed its previously announced private placement of 6,106,870 common shares on October 19, 2026. Under a registration rights agreement, the company must file or confidentially submit an SEC registration statement covering investors’ share resales within 30 days of closing.
